Pharmaceutical Technology Europe - June 2012 - (Page 14)

Is Pharma Getting the Best out of Social Media? We speak with Cognizant’s Bhaskar Sambasivan to find out where pharma is when it comes to social media implementation and what more should be being done. Y NE LI E, TR ON RE EN F ER R OW ST FO H GI W K S RE NO AC R -T ST FA Are pharma companies using social media to its full potential? Despite the challenges, many pharmaceutical companies are broadening the way they use social media. For instance, as well as using platforms like Twitter and Facebook for distributing press releases and other company announcements, many companies also use them to promote awareness of health issues and diseases, or to manage corporate affairs or share corporate social responsibility initiatives. correct. In 2011, for example, many pharmaceutical companies were forced to shut down their Facebook pages after Facebook stopped offering the companies an option to moderate public comments on the respective pages. All social media brand pages leave companies open and vulnerable to negative comments from disappointed customers and activists, which can be damaging to a brand’s reputation. PTE 13-14 June 2012 Gran Via Exhibition Center Barcelona | Spain www.chemspeceurope.com Connect at Chemspec SCAN HERE TO REGISTER NOW Learn | Meet | Share Biocides Biotechnology Coatings Contract & toll manufacture Contract research Cosmetics & personal care Chemspec Europe is your gateway to the custom, ﬁne and speciality chemicals industry. Connect with manufacturers, suppliers and end-users from a wealth of sectors including: Crop protection Flame retardants Pharmaceuticals Polymers Surfactants Water treatment With a focused range of exhibits, easily identiﬁed feature zones, free-to-attend conferences and seminars in a relaxed atmosphere with quality ‘face-time’, there is no better place to connect and do business. What are the limitations of popular social media platforms? One of the biggest limitations of social media is the inability to moderate uncontrolled comments, which can be inappropriate and may not always be factually Bhaskar Sambasivan is vice president and head of life sciences, Europe, Cognizant. Organised by: CONTACT THE SALES TEAM: John Lane T: +44 (0) 1737 855076 E: johnlane@quartzltd.co.uk In association with: Incorporating: Ofﬁcial media partner: Read the full interview at: PharmTech.com/Sambasivan 2 Analytical Stability 11 Freeze Drying Optimisation 3 Aseptic Filling 12 Hot Melt Extrusion 4 News 14 Interview 10 Manufacturing 16 Ask the Expert http://www.chemspeceurope.com http://www.chemspeceurope.com http://www.chemspeceurope.com http://www.PharmTech.com/Sambasivan

Table of Contents for the Digital Edition of Pharmaceutical Technology Europe - June 2012

Pharmaceutical Technology Europe - June 2012
Contents
Analytical Stability
Aseptic Filling
News
Blogs Abridged
Cleaning
Manufacturing
Freeze Drying Optimisation
Hot Melt Extrusion
Column Crunch: Biomanufacturing; European Regulators Struggle
Interview
Ask the Expert

Pharmaceutical Technology Europe - June 2012